A recent report of two individual patients with prodromal Parkinson’s disease [67] suggests that treatment with the modified amino acid acetyl-DL-leucine not only improves symptoms but also reverses the loss of striatal DAT as assessed by [123I]FP-CIT SPECT. Here, SLC6A3 is linked to Parkinson disease.